Release Date: 28/02/13 15:47 Summary: Calliden 2012 Full Year Results and Outlook for 2013 Price Sensitive: No Download Document Not available as of the moment. Download
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025